
Opinion|Videos|August 1, 2024
Current Standard of Care in IPF
Author(s)Justin Oldham, MD, MS
Justin Oldham, MD, MS, discusses the current standard of car in treating idiopathic pulmonary fibrosis and the role of non-pharmacologic therapies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the current standard of care in treating IPF?
- What is the role of non-pharmacologic therapies in this disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
5